The Role of Intravenous Methylprednisolone Immunosuppression in the Management of Active Thyroid Eye Disease

Author： Tambe Katya   Bhargava Jonathan   Tripathi Ajay   Gregory Marelena   Burns Joyce   Sampath Raghavan  

Publisher： Informa Healthcare

ISSN： 0167-6830

Source： Orbit, Vol.29, Iss.5, 2010-10, pp. : 227-231

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thyroid-associated eye disease

By Heufelder Armin E.   Joba Werner  

Strabismus, Vol. 8, Iss. 2, 2000-06 ,pp. : 101-111

Informa Healthcare

Access to resources Recommend Favorite

Thyroid Eye Disease: Pathogenesis and Treatment

By  

Ophthalmologica, Vol. 224, Iss. 4, 2009-11 ,pp. : 199-203

Karger

Access to resources Recommend Favorite

The Management of Patients with Thyroid Eye Disease After Bilateral Orbital 3 Wall Decompression

By Maino AP   Dawson EL   Adams GGW   Rose GE   Lee JP  

Strabismus, Vol. 19, Iss. 2, 2011-06 ,pp. : 35-37

Informa Healthcare

Access to resources Recommend Favorite

Tumors Masquerading in Patients with Thyroid Eye Disease

By Griepentrog Gregory J.   Burkat Cat N.   Kikkawa Don O.   Lucarelli Mark J.  

Orbit, Vol. 32, Iss. 4, 2013-08 ,pp. : 260-262

Informa Healthcare

Access to resources Recommend Favorite

Recent Developments in the Medical Treatment of Thyroid Eye Disease

By Krassas G.   Boboridis K.  

Orbit, Vol. 25, Iss. 2, 2006-06 ,pp. : 117-122

Informa Healthcare

Access to resources Recommend Favorite